Locations:
Search IconSearch
January 18, 2021/Neurosciences/Podcast

Early Adopter of Mobile Stroke Care Shares Operational Insights (Podcast)

Learnings on cost-effectiveness, working with municipalities and more

“Even 15 minutes can be the difference in a patient’s ability to walk after a stroke,” says Andrew Russman, DO, Medical Director of the Comprehensive Stroke Center and Mobile Stroke Treatment Unit in Cleveland Clinic’s Cerebrovascular Center. “And the time savings significantly reduces hospital mortality after acute ischemic stroke.”

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Cleveland Clinic’s mobile stroke unit was one of the first in the U.S., launched in 2014. As an early adopter, Dr. Russman shares insights on mobile stroke care in the newest episode of Cleveland Clinic’s Neuro Pathways podcast. Topics he discusses include:

  • Collaborating with municipalities and identifying a mobile stroke unit’s coverage area
  • Cost effectiveness of providing a mobile stroke unit
  • How patients with intracerebral hemorrhage are managed on the mobile unit

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Russman: The Mobile Stroke Treatment Unit has a dedicated team that includes a critical care nurse, paramedic, emergency medical technician, CT technologist and, through a two-way audio-visual connection, a vascular neurologist. This team is essential to the operation of the unit, and it works with local emergency medical services (EMS) and the local EMS dispatch system.

When a patient calls 911, the dispatcher identifies that the patient is having stroke symptoms. Then they dispatch both the Mobile Stroke Treatment Unit and the local EMS unit to the patient’s location. The first responders (the local EMS unit) go into the home, identify the patient and the stroke symptoms, and then wave in members of the mobile stroke unit waiting at the patient’s doorstep. At that point, the patient is taken from the home and loaded onto the mobile stroke unit.

Advertisement

The first thing we do is work on getting IV access. We also obtain a noncontrast CT scan of the brain and complete a neurologic assessment using the National Institutes of Health Stroke Scale. A clinical decision is made after viewing the CT imaging, seeing the clinical exam and determining whether the patient is a candidate for thrombolysis (with IV tissue plasminogen activator) or has a potential large-vessel occlusion.

Our plan is to take the patient to a facility within their existing system of care, but it needs to be a hospital with the right capability. Patients with large blood vessel occlusions are taken to facilities able to perform endovascular therapy and retrieve the clot.

A lot of collaboration is involved. We work with local EMS and fire departments. We work with teams in emergency departments, and we work together within our own team to optimize these processes, share information with our partners and continue to improve our performance to provide the best clinical outcome for patients.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad